Status:
WITHDRAWN
The Impact of Covid-19 on Skeletal Muscle
Lead Sponsor:
University of Nottingham
Conditions:
Covid19
Muscle Loss
Eligibility:
All Genders
40+ years
Brief Summary
With the recent worldwide outbreak of the COVID-19 infection and the huge impact it has had upon lives in the UK, it is key to increase knowledge on the impact of the virus on the body. Certain aspect...
Detailed Description
Since the outbreak of the COVID-19 pandemic worldwide, there have been over 50,000 deaths and over 1million infections in the UK alone. It has been widely reported that infection with COVID-19 leads t...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 infection as confirmed by PCR swab, or being treated for non-COVID-19 community acquired pneumonia
- A minimum of oxygen treatment required for 24hours.
- Capacity to give informed and written consent
Exclusion
- A BMI \<16.5 or \>35 kg/m2
- Active cardiovascular disease:
- Significant arrhythmia
- Recent acute coronary event
- Cerebrovascular disease:
- Recent stroke
- Respiratory disease including:
- Pulmonary hypertension
- Significant COPD
- Uncontrolled asthma
- Clotting dysfunction or current use of anticoagulants (eg Warfarin/Clopidogrel/ Rivaroxaban)
- Significant musculoskeletal or neurological disorders
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04756674
Start Date
March 10 2021
End Date
October 1 2022
Last Update
June 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Derby Hospital
Derby, Derbyshire, United Kingdom, DE223NE